• Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Lalpathlab Share Price

    Dr. Lal Pathlabs Share PriceDr. Lal Pathlabs

    Large Cap 6.2k Result
    ₹2,669.00
    21.45 (0.81%)
    • Advice
    • Hold
    As on 30 November, 2023 | 06:44 BSE: 539524 NSE: LALPATHLABISIN: INE600L01024

    Dr. Lal Pathlabs Performance

    Day Range

    • Low 2,642.55
    • High 2,685.75
    ₹ 2,669.00

    52 Week Range

    • Low 1,762.05
    • High 2,767.10
    ₹ 2,669.00
    • Open Price2,652.80
    • Previous Close2,647.55
    • Volume189857

    Start SIP in Dr. Lal Pathlabs

    Start SIP

    Dr. Lal Pathlabs Share Price

    • Over 1 Month 12.95%
    • Over 3 Month 22.91%
    • Over 6 Month 30.47%
    • Over 1 Year 10.57%

    Dr. Lal Pathlabs Key Statistics

    P/E Ratio 73.9
    PEG Ratio 3.4
    Market Cap Cr 22,280
    Price to Book Ratio 13.1
    EPS 34.9
    Dividend 0.4
    Relative Strength Index 56.44
    Money Flow Index 53.94
    MACD Signal 57.09
    Average True Range 75.92

    Dr. Lal Pathlabs F&O

    Dr. Lal Pathlabs Futures
    Dr. Lal Pathlabs Option Chain

    Dr. Lal Pathlabs Investment Rating

    • Master Rating:

    • Dr Lal Pathlabs has an operating revenue of Rs. 2,122.70 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 17% is great, ROE of 14% is good. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 21% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Dr. Lal Pathlabs Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 532480431428467439415
    Operating Expenses Qtr Cr 369344315324337330310
    Operating Profit Qtr Cr 163136116104130109105
    Depreciation Qtr Cr 19182121211922
    Interest Qtr Cr 778810811
    Tax Qtr Cr 38322722282220
    Net Profit Qtr Cr 113947162798065
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,8161,926
    Operating Expenses Annual Cr 1,3081,362
    Operating Profit Annual in Cr 461510
    Depreciation Cr 8275
    Interest Annual Cr 3429
    Tax Annual Cr 98115
    Net Profit Annual Cr 292344
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 428424
    Cash from Investing Activity Annual Cr -288-449
    Cash from Financing Annual Activity Cr -270142
    Net Cash Flow Annual Cr -131117
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,6901,476
    Fixed Assets Annual Cr 366385
    Total Non Current Assets Annual Cr 1,5101,518
    Total Current Assets Annual Cr 810696
    Total Assets Annual Cr 2,3202,214
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 203177
    ROE Annual % 1723
    ROCE Annual % 2328
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2930
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 601541491489534503486
    Operating Expenses Qtr Cr 424395375376390385364
    Operating Profit Qtr Cr 178146116113144118121
    Depreciation Qtr Cr 36353838393638
    Interest Qtr Cr 889911912
    Tax Qtr Cr 42342623302321
    Net Profit Qtr Cr 109835753725861
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 2,0592,140
    Operating Expenses Annual Cr 1,5271,527
    Operating Profit Annual in Cr 490561
    Depreciation Cr 150108
    Interest Annual Cr 3830
    Tax Annual Cr 103125
    Net Profit Annual Cr 239345
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 456447
    Cash from Investing Activity Annual Cr -287-449
    Cash from Financing Annual Activity Cr -283136
    Net Cash Flow Annual Cr -114134
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,6661,508
    Fixed Assets Annual Cr 762840
    Total Non Current Assets Annual Cr 1,4121,478
    Total Current Assets Annual Cr 973875
    Total Assets Annual Cr 2,3862,353
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 204185
    ROE Annual % 1423
    ROCE Annual % 2027
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2629
    Invest in Dr. Lal Pathlabs

    Dr. Lal Pathlabs Technicals

    EMA & SMA

    Current Price
    ₹2,669.00
    21.45 (0.81%)
    pointer
    • Bullish Moving Average
    • ___
    • 15
    • Bearish Moving Average
    • ___
    • 1
    • 20 Day
    • ₹2,630.63
    • 50 Day
    • ₹2,532.79
    • 100 Day
    • ₹2,422.48
    • 200 Day
    • ₹2,335.85
    • 20 Day
    • ₹2,643.93
    • 50 Day
    • ₹2,525.43
    • 100 Day
    • ₹2,412.10
    • 200 Day
    • ₹2,190.18

    Dr. Lal Pathlabs Resistance and Support

    PIVOT
    ₹2,665.77
    Resistance
    First Resistance 2,688.98
    Second Resistance 2,708.97
    Third Resistance 2,732.18
    RSI 56.44
    MFI 53.94
    MACD Single Line 57.09
    MACD 48.86
    Support
    First Resistance 2,645.78
    Second Resistance 2,622.57
    Third Resistance 2,602.58

    Dr. Lal Pathlabs Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 191,330 11,558,245 60.41
    Week 289,456 11,725,852 40.51
    1 Month 346,970 12,126,595 34.95
    6 Month 278,787 10,315,106 37

    Dr. Lal Pathlabs Result Highlights

    Dr. Lal Pathlabs Synopsis

    NSE-Medical-Services

    Dr. Lal Pathlabs Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1769.03 Cr. and Equity Capital is Rs. 83.37 Cr. for the Year ended 31/03/2023. Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388.
    Market Cap 22,280
    Sales 1,871
    Shares in Float 3.76
    No of funds 290
    Yield 0.45
    Book Value 13.17
    U/D Vol ratio 1.9
    LTDebt / Equity 5
    Alpha 0.03
    Beta 0.68

    Dr. Lal Pathlabs

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 54.61%55.01%55.03%55.05%
    Mutual Funds 5.36%4.92%3.26%2.71%
    Insurance Companies 2.61%2.41%2.28%2.37%
    Foreign Portfolio Investors 24.35%23.27%23.06%23.8%
    Financial Institutions/ Banks
    Individual Investors 8.37%9.31%9.5%9.02%
    Others 4.7%5.08%6.87%7.05%

    Dr. Lal Pathlabs Management

    Name Designation
    Brig.(Hony) Dr. Arvind Lal Executive Chairman
    Dr. Om Prakash Manchanda Managing Director
    Dr. Vandana Lal Executive Director
    Mr. Rahul Sharma Non Executive Director
    Dr. Archana Lal Erdmann Non Executive Director
    Mr. Sunil Varma Lead Independent Director
    Mr. Anoop Mahendra Singh Independent Director
    Mr. Harneet Singh Chandhoke Independent Director
    Dr. Saurabh Srivastava Independent Director
    Mrs. Somya Satsangi Independent Director
    Mr. Rohit Bhasin Independent Director
    Mr. Arun Duggal Independent Director
    Mr. Gurinder Singh Kalra Independent Director
    Mr. Rajit Mehta Independent Director

    Dr. Lal Pathlabs Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Dr. Lal Pathlabs Corporate Action

    Date Purpose Remarks
    2023-11-02 Quarterly Results
    2023-07-27 Quarterly Results & Interim Dividend
    2023-05-11 Audited Results & Final Dividend
    2023-02-02 Quarterly Results
    2022-11-08 Quarterly Results
    Date Purpose Remarks
    2023-08-11 FINAL Rs.6.00 per share(60%)Final Dividend
    2023-08-11 INTERIM Rs.6.00 per share(60%)Interim Dividend
    2022-08-09 INTERIM Rs.6.00 per share(60%)Interim Dividend
    2022-06-23 FINAL Rs.6.00 per share(60%)Final Dividend
    2021-08-22 INTERIM Rs.6.00 per share(60%)Interim Dividend

    Dr. Lal Pathlabs MF Shareholding

    Name Amount(cr)
    Kotak Equity Arbitrage Fund Growth 28,958
    UTI Flexi Cap Fund Regular Plan Growth 24,370
    SBI Arbitrage Opportunities Fund Regular Growth 22,370
    Canara Robeco Emerging Equities Growth 17,563
    SBI Large & Midcap Fund Regular Payout Inc Dist cum Cap Wdrl 15,649

    Dr. Lal Pathlabs FAQs

    What is Share Price of Dr. Lal Pathlabs ?

    Dr. Lal Pathlabs share price is ₹2,669 As on 30 November, 2023 | 06:30

    What is the Market Cap of Dr. Lal Pathlabs ?

    The Market Cap of Dr. Lal Pathlabs is ₹22280.3 Cr As on 30 November, 2023 | 06:30

    What is the P/E ratio of Dr. Lal Pathlabs ?

    The P/E ratio of Dr. Lal Pathlabs is 73.9 As on 30 November, 2023 | 06:30

    What is the PB ratio of Dr. Lal Pathlabs ?

    The PB ratio of Dr. Lal Pathlabs is 13.1 As on 30 November, 2023 | 06:30

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.